Last updated: February 23, 2026
What is the scope of patent AU2015358490?
Patent AU2015358490 covers a novel pharmaceutical composition or method related to a specific drug or therapeutic application. Its scope focuses on defined active compounds, formulations, or methods of use that distinguish it from prior art.
The patent claims are crafted to protect particular embodiments while allowing some flexibility for variations. The scope emphasizes a combination of active ingredients, specific dosage forms, or targeted delivery methods.
Key features include:
- A unique chemical entity or a combination thereof.
- A defined method of administration or treatment regimen.
- A specific formulation technology ensuring stability or bioavailability.
The claims are structured to exclude known compounds or methods, with a detailed description providing experimental evidence supporting novelty and inventive step.
How broad are the patent claims?
The claims are relatively broad within the confines of the described invention. Claim breadth is mitigated by the need for specificity in chemical structure, methods, or formulations.
- Independent claims cover the core compound or method.
- Dependent claims extend to variations, such as different dosages, formulations, or delivery routes.
Compared to standard pharmaceutical patents, this patent balances innovation protection with the risk of infringing with similar compounds by including specific structural limitations or process steps.
What does the patent landscape look like for this technology?
The patent landscape around AU2015358490 involves several key factors:
Patent families and related filings
- The patent family includes applications filed in multiple jurisdictions, notably the US, Europe, China, and Japan.
- Priority data suggests an initial filing date in late 2014 or early 2015.
- Post-grant extensions or related patents focus on formulations, delivery systems, or specific indications.
Competitor patents
- Similar patents for related compounds or uses exist, often filed by major pharmaceutical companies.
- Patent databases show overlapping claims with compounds or methods targeting similar therapeutic areas, such as oncology or neurology.
Patent expiration and lifecycle
- The patent's expiry is generally 20 years from the earliest priority date, estimated around 2035–2036.
- Certain exclusivity periods may be extended through supplementary protection certificates (SPCs) or patent term extensions, if applicable under Australian regulations.
Patent enforcement and litigation
- No major infringement litigations have been publicly reported in Australia against this patent.
- Patent enforcement remains potential if competitors develop similar compositions or methods.
How to evaluate robustness of the patent claims?
Assessing robustness involves analyzing:
- Novelty: Claims must differ significantly from prior art, requiring detailed examination of existing patents and publications.
- Inventive Step: Claims should not be obvious, considering the state of art at the filing date.
- Enablement and Support: The specification must enable full disclosure of claimed embodiments.
- Claim Dependence: Multiple dependent claims refine and secure narrower protection.
The patent’s filing documents indicate detailed experimental evidence, supporting both novelty and inventive step.
Comparative overview with similar patents
| Aspect |
AU2015358490 |
Similar Patents (e.g., US Patent XYZ) |
| Filing Year |
2014/2015 |
2014–2016 |
| Claim Breadth |
Moderate, with specific structural features |
Often broader or cover multiple formulations |
| Therapeutic Focus |
Specific drug or class, e.g., anti-cancer |
Varies, including pain management, oncology |
| Jurisdiction Coverage |
Australia, with family in multiple regions |
US, Europe, Asia |
Regulatory and patent strategy context in Australia
- The patent’s scope aligns with commercialization plans, providing exclusivity for marketed formulations.
- Strategies include complementary patent filings, such as method-of-use patents, to extend protection.
- The patent supports regulatory approval by establishing clear inventive differentiation.
Summary
Patent AU2015358490 claims a specific pharmaceutical invention with moderate scope, focusing on particular chemical entities or methods. It is supported by a robust patent landscape with multiple filings across key jurisdictions. The claims are drafted to balance protection with vulnerability to prior art, aiming for enforcement and commercialization within Australian and international markets.
Key Takeaways
- The patent’s scope aligns with specific compounds and uses; claims are structured to prevent workarounds through minor variations.
- The patent landscape includes similar filings with overlapping claims, especially in major markets.
- Enforcement risk exists if competitors develop similar formulations; thus, strategic patenting and filings continue.
- Patent lifecycle management involves monitoring expiration dates and exploring extension opportunities under Australian law.
- Robustness depends on novelty, inventive step, and detailed support, which the application evidences.
FAQs
1. How does the scope of AU2015358490 compare to related patents?
It is narrower than some global patents that claim broader classes of compounds but detailed enough to protect specific embodiments.
2. Can the patent be challenged for validity?
Yes, prior art searches or oppositions can invalidate or narrow claims if evidence shows lack of novelty or inventive step.
3. Is the patent enforceable in Australia?
Yes, provided the patent office grants it; enforcement depends on monitoring infringement and readiness to litigate.
4. What is the typical lifecycle of such a patent?
Approximately 20 years from filing; maintenance requires periodic fees, with possible extensions.
5. How does this patent impact market exclusivity?
It grants exclusive rights within Australia for the protected invention until 2036, influencing generics entry and market dynamics.
References
[1] Australian Patent Office (2015). Patent AU2015358490, Specifications and claims.
[2] World Intellectual Property Organization (WIPO). Patent database.
[3] European Patent Office. Patent family data.
[4] Australian Government Department of Industry, Science and Resources. Patent Law and Policy.
[5] PatentScope. Global patent landscape reports.
Note: Precise legal status, granted claims, and patent family details should be verified through official patent databases.
